- Home
- GMGI vs IMMP Comparison
GMGI vs IMMP Comparison
Compare GMGI & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMGI
- IMMP
- Stock Information
- Founded
- GMGI 2008
- IMMP 1987
- Country
- GMGI United States
- IMMP Australia
- Employees
- GMGI N/A
- IMMP N/A
- Industry
- GMGI Computer Software: Prepackaged Software
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- GMGI Technology
- IMMP Health Care
- Exchange
- GMGI Nasdaq
- IMMP Nasdaq
- Market Cap
- GMGI 255.9M
- IMMP 211.1M
- IPO Year
- GMGI N/A
- IMMP N/A
- Fundamental
- Price
- GMGI $2.07
- IMMP $1.55
- Analyst Decision
- GMGI Strong Buy
- IMMP Buy
- Analyst Count
- GMGI 1
- IMMP 2
- Target Price
- GMGI $4.00
- IMMP $8.50
- AVG Volume (30 Days)
- GMGI 127.6K
- IMMP 81.3K
- Earning Date
- GMGI 05-12-2025
- IMMP 05-02-2025
- Dividend Yield
- GMGI N/A
- IMMP N/A
- EPS Growth
- GMGI N/A
- IMMP N/A
- EPS
- GMGI N/A
- IMMP N/A
- Revenue
- GMGI $151,115,532.00
- IMMP $3,019,249.00
- Revenue This Year
- GMGI $34.49
- IMMP N/A
- Revenue Next Year
- GMGI $12.92
- IMMP $20.28
- P/E Ratio
- GMGI N/A
- IMMP N/A
- Revenue Growth
- GMGI 62.50
- IMMP 24.11
- 52 Week Low
- GMGI $1.70
- IMMP $1.32
- 52 Week High
- GMGI $6.27
- IMMP $3.34
- Technical
- Relative Strength Index (RSI)
- GMGI 53.00
- IMMP 39.93
- Support Level
- GMGI $1.79
- IMMP $1.44
- Resistance Level
- GMGI $2.11
- IMMP $1.56
- Average True Range (ATR)
- GMGI 0.13
- IMMP 0.12
- MACD
- GMGI 0.01
- IMMP 0.00
- Stochastic Oscillator
- GMGI 78.57
- IMMP 41.63
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company that develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers, located in the Asia Pacific region. The company operates in two reportable segments; B2B and B2C. The B2C segment earns majority revenue. The company operates in UK, Asia Pacific and Latin America. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, R Kings Competitions and GM-AG.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.